|
DLST expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.50115508701765E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.50129908504937E-11 |
| Normal-vs-Stage2 |
3.61640000000607E-05 |
| Normal-vs-Stage3 |
3.7669000000351E-06 |
| Normal-vs-Stage4 |
4.27389999946293E-07 |
| Stage1-vs-Stage2 |
9.889800E-01 |
| Stage1-vs-Stage3 |
8.005200E-01 |
| Stage1-vs-Stage4 |
4.242200E-01 |
| Stage2-vs-Stage3 |
8.609200E-01 |
| Stage2-vs-Stage4 |
5.362400E-01 |
| Stage3-vs-Stage4 |
6.754600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.94215779411888E-12 |
| Normal-vs-AfricanAmerican |
2.80349965464666E-10 |
| Normal-vs-Asian |
6.36729999999863E-05 |
| Caucasian-vs-AfricanAmerican |
9.616200E-01 |
| Caucasian-vs-Asian |
5.967400E-01 |
| AfricanAmerican-vs-Asian |
5.930600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.97801799781428E-12 |
| Normal-vs-Female |
2.42460496124863E-11 |
| Male-vs-Female |
7.406800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.88289972291989E-10 |
| Normal-vs-Extreme_Weight |
3.94306809425871E-12 |
| Normal-vs-Obese |
2.25709995138601E-09 |
| Normal-vs-Extreme_Obese |
9.789500E-02 |
| Normal_Weight-vs-Extreme_Weight |
8.389400E-01 |
| Normal_Weight-vs-Obese |
3.706600E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.609600E-02 |
| Extreme_Weight-vs-Obese |
3.842400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.856100E-02 |
| Obese-vs-Extreme_Obese |
1.033830E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.22789999945638E-07 |
| Normal-vs-Age(41-60Yrs) |
4.96029883834126E-11 |
| Normal-vs-Age(61-80Yrs) |
4.46254144748082E-12 |
| Normal-vs-Age(81-100Yrs) |
5.76080000036505E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.280600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.114400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.464200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.400000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.838600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.626600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.0805137047073E-12 |
| Normal-VS-Type2 PRCC |
2.39690045589214E-10 |
| Normal-VS-KIRP CIMP |
1.10110000006713E-08 |
| Normal-VS-Unclassified PRCC |
7.41949999993885E-07 |
| Type1 PRCC-VS-Type2 PRCC |
7.481800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.921600E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
8.508600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.302410E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.739000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.661810E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.82170001306048E-09 |
| Normal-vs-N1 |
4.43200000033173E-08 |
| Normal-vs-N2 |
3.5505000051117E-08 |
| N0-vs-N1 |
2.180600E-01 |
| N0-vs-N2 |
2.345600E-02 |
| N1-vs-N2 |
1.261000E-01 |
|
|
